Benign prostatic hyperplasia (BPH) is a common urological condition among middle-aged and older men that can significantly reduce overall quality of life beyond simple urinary discomfort. Typical symptoms include a weak urinary stream, interruption of urination, a feeling of incomplete bladder emptying, and frequent urination. If such symptoms are suspected, it is important not to ignore them and to visit a urology clinic for a thorough evaluation.
Before initiating treatment for BPH, identifying the exact cause of the symptoms is essential. This typically involves several diagnostic tests, including the International Prostate Symptom Score (IPSS), digital rectal examination, prostate-specific antigen (PSA) testing, uroflowmetry, post-void residual urine measurement, and ultrasound examination. These tests provide a comprehensive understanding of the patient’s condition and guide the treatment plan.
One of the treatment methods that has recently gained wider use is aquablation surgery. Often referred to as “waterjet robotic surgery,” this technique removes enlarged prostate tissue using a high-pressure water jet without generating thermal damage. Unlike conventional transurethral resection of the prostate (TURP), aquablation can effectively relieve symptoms while minimizing damage to surrounding healthy tissues.
Aquablation has been approved by the U.S. Food and Drug Administration (FDA) and recognized as a new medical technology in Korea, with its safety and effectiveness already established. Because the procedure does not rely on heat, it also has the advantage of a lower risk of complications such as urinary incontinence or erectile dysfunction.
However, an important factor in achieving successful aquablation treatment is the experience and skill of the surgeon. The procedure involves precisely removing prostate tissue based on robotic technology guided by ultrasound and endoscopic imaging. Therefore, the surgeon must have a thorough understanding of prostate anatomy and the ability to control the robotic system with precision. Without sufficient expertise, treatment outcomes may vary. No matter how advanced the technology becomes, the results ultimately depend on the person operating the equipment.
Each patient with BPH presents with different characteristics, including prostate size and shape, the degree of bladder outlet obstruction, and the presence of other medical conditions. As a result, the way the surgical plan is designed can significantly influence treatment outcomes. Experienced surgeons can accurately assess each patient’s condition, determine the optimal extent of tissue removal, and respond effectively to unexpected situations during the procedure.
Dr. Jo Jung-ho of Goldman Urology Clinic’s Gangnam branch emphasized that in order to fully benefit from aquablation treatment, advanced medical equipment must be combined with the expertise of a skilled surgeon. He advised that patients should consider not only the name of the surgical technique but also who will perform the procedure, as this is a critical factor in the successful treatment of benign prostatic hyperplasia.